RESEARCH-USE BIOSIMILAR ANTIBODY

Bebtelovimab

Monoclonal antibody · IgG1

SARS-CoV-2 Spike RBDIgG1RUO

Bebtelovimab is a research-use biosimilar reference antibody targeting SARS-CoV-2 Spike RBD.

TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-738
CATALOG NUMBERSC-BS-738
MOLECULAR WEIGHTApprox. 143.82 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Bebtelovimab is a research-use biosimilar reference antibody targeting SARS-CoV-2 Spike RBD.

Bebtelovimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte